U.S. Physical Therapy (NYSE:USPH) Announces Quarterly Earnings Results, Misses Estimates By $0.09 EPS

U.S. Physical Therapy (NYSE:USPH) announced its quarterly earnings results on Tuesday. The company reported $0.73 earnings per share for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09), Briefing.com reports. U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The firm had revenue of $167.19 million during the quarter, compared to analysts’ expectations of $163.34 million. The company’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.76 EPS.

U.S. Physical Therapy Price Performance

Shares of USPH traded up $1.12 during midday trading on Friday, reaching $84.21. The stock had a trading volume of 142,906 shares, compared to its average volume of 86,112. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.88 and a quick ratio of 2.16. The company has a market capitalization of $1.27 billion, a P/E ratio of 68.46, a P/E/G ratio of 3.17 and a beta of 1.38. The firm’s 50 day moving average price is $93.37 and its 200-day moving average price is $99.57. U.S. Physical Therapy has a 52 week low of $78.08 and a 52 week high of $113.63.

U.S. Physical Therapy Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 13th. Shareholders of record on Friday, August 23rd will be given a $0.44 dividend. The ex-dividend date is Friday, August 23rd. This represents a $1.76 dividend on an annualized basis and a yield of 2.09%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 143.09%.

Analyst Upgrades and Downgrades

USPH has been the topic of several recent research reports. StockNews.com lowered U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research note on Tuesday. Barrington Research cut their price objective on shares of U.S. Physical Therapy from $122.00 to $108.00 and set an “outperform” rating for the company in a research report on Thursday. One research analyst has rated the stock with a sell rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $112.50.

Insider Buying and Selling

In other news, CEO Christopher J. Reading sold 1,100 shares of the firm’s stock in a transaction on Tuesday, May 28th. The stock was sold at an average price of $102.13, for a total transaction of $112,343.00. Following the completion of the sale, the chief executive officer now directly owns 99,738 shares of the company’s stock, valued at approximately $10,186,241.94. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, CEO Christopher J. Reading sold 1,100 shares of the stock in a transaction on Tuesday, May 28th. The stock was sold at an average price of $102.13, for a total value of $112,343.00. Following the completion of the sale, the chief executive officer now owns 99,738 shares in the company, valued at $10,186,241.94. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Christopher J. Reading sold 2,900 shares of the stock in a transaction dated Thursday, May 30th. The stock was sold at an average price of $100.26, for a total value of $290,754.00. Following the completion of the sale, the chief executive officer now directly owns 95,838 shares of the company’s stock, valued at $9,608,717.88. The disclosure for this sale can be found here. 1.70% of the stock is owned by corporate insiders.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.